Christopher T. Harbison
Memorial Sloan Kettering Cancer Center
3 papers in the Anchorcite directory, published between 2014 and 2015, cited 22,373 times in total.
Research topics
- Cancer Immunotherapy and Biomarkers · 3 papers
- Lung Cancer Diagnosis and Treatment · 2 papers
- Lung Cancer Treatments and Mutations · 2 papers
- Immunotherapy and Immune Responses · 1 paper
- Cutaneous Melanoma Detection and Management · 1 paper
Frequent co-authors
- Luis G Paz-Ares · 2 papers
- David Robert Spigel · 2 papers
- Martin B. Steins · 2 papers
- Neal Ready · 2 papers
- Everett E. Vokes · 2 papers
- Esther Holgado · 2 papers
- Elena V Poddubskaya · 2 papers
- Scott Joseph Antonia · 2 papers
Papers
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung CancerNew England Journal of Medicine · 2015 · 9,473 citations
BACKGROUND: Nivolumab, a fully human IgG4 programmed death 1 (PD-1) immune-checkpoint-inhibitor antibody, disrupts PD-1-mediated signaling and may restore antitumor immunity. METHODS: In this randomized, open-label, international phase 3 study, we assigned patients with nonsquamous non-small-cell lung cancer (NSCLC) that had…
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung CancerNew England Journal of Medicine · 2015 · 8,551 citations
BACKGROUND: Patients with advanced squamous-cell non-small-cell lung cancer (NSCLC) who have disease progression during or after first-line chemotherapy have limited treatment options. This randomized, open-label, international, phase 3 study evaluated the efficacy and safety of nivolumab, a fully human IgG4…
- Genetic Basis for Clinical Response to CTLA-4 Blockade in MelanomaNew England Journal of Medicine · 2014 · 4,349 citations
BACKGROUND: Immune checkpoint inhibitors are effective cancer treatments, but molecular determinants of clinical benefit are unknown. Ipilimumab and tremelimumab are antibodies against cytotoxic T-lymphocyte antigen 4 (CTLA-4). Anti-CTLA-4 treatment prolongs overall survival in patients with melanoma. CTLA-4 blockade activates T…
Metadata from OpenAlex (CC0).